Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / bioventus inc bvs q1 2024 earnings call transcript


BVS - Bioventus Inc. (BVS) Q1 2024 Earnings Call Transcript

2024-05-07 12:02:13 ET

Bioventus, Inc. (BVS)

Q1 2024 Earnings Conference Call

May 07, 2024, 08:30 ET

Company Participants

Dave Crawford - VP, IR & Treasurer

Robert Claypoole - President, CEO & Director

Mark Singleton - CFO & SVP

Conference Call Participants

Chase Knickerbocker - Craig-Hallum

Robbie Marcus - JPMorgan Chase & Co.

Caitlin Cronin - Canaccord Genuity

Presentation

Operator

Good day, and welcome to the Bioventus first-quarter 2024 earnings conference call. [Operator Instructions].

I would now like to hand the call over to Dave Crawford, Vice President of Investor Relations. Please go ahead.

Dave Crawford

Thank you, Andrea, and good morning, everyone, and thanks for joining us. It is my pleasure to welcome you to the Bioventus 2024 first-quarter earnings conference call. With me this morning are Rob Claypoole, President and CEO; and Mark Singleton, Senior Vice President and CFO. Rob will begin his remarks with an update on our 2024 priorities in our business. Mark will provide detail of our first-quarter results and discuss our updated 2024 financial guidance. We will finish the call with Q&A. Our presentation for today's call is available on the investors section of our website, bioventus.com.

But before we begin, I would like to remind everyone that our remarks today contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the SEC, including Item 1A, Risk Factors of the company's Form 10-K for the year ended December 31, 2023. And as such factors may be updated from time to time in the company's other filings made with the Securities and Exchange Commission....

For further details see:

Bioventus, Inc. (BVS) Q1 2024 Earnings Call Transcript
Stock Information

Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Website: bioventus.com

Menu

BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...